Case report: Clinical and histopathological characteristics of psoriasiform erythema and de novo IL-17A cytokines expression on lesioned skin in atopic dermatitis children treated with dupilumab

BACKGROUND: Atopic dermatitis (AD) is a chronic recurrent inflammatory disease, and dupilumab, a human monoclonal antibody, is the firstly approved biological drug for AD. Psoriasiform erythema (PE) during dupilumab treatment in adults has been reported. This study describes the risk of PE in childr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Kamran, Wu, Liming, Qiu, YunMi, Li, Menghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366075/
https://www.ncbi.nlm.nih.gov/pubmed/35966849
http://dx.doi.org/10.3389/fmed.2022.932766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366075/
https://www.ncbi.nlm.nih.gov/pubmed/35966849
http://dx.doi.org/10.3389/fmed.2022.932766

Ejemplares similares